Haemek Medical Center

Afula, Northern District 1834111

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Myelodysplastic Syndromes

Studies at this site

• Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) — Running, not enrolling
• A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery — Running, not enrolling